- Home
- HSDT vs XGN Comparison
HSDT vs XGN Comparison
Compare HSDT & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSDT | XGN |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.1M | 110.8M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HSDT | XGN |
|---|---|---|
| Price | $2.82 | $3.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | 432.8K | ★ 661.5K |
| Earning Date | 11-18-2025 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $941,000.00 | ★ $63,599,000.00 |
| Revenue This Year | N/A | $21.40 |
| Revenue Next Year | $75.13 | $14.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 87.45 | 14.08 |
| 52 Week Low | $2.62 | $2.67 |
| 52 Week High | $592.50 | $12.23 |
Technical Indicators
Market Signals| Indicator | HSDT | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 41.52 | 17.54 |
| Support Level | $2.80 | $4.41 |
| Resistance Level | $3.19 | $5.05 |
| Average True Range (ATR) | 0.36 | 0.46 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 15.50 | 1.72 |
Price Performance
Historical ComparisonAbout HSDT Helius Medical Technologies Inc. (DE)
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.